Clinical Trial
Published on 15 Nov 2024
in Drug Metabolism and Transport
![Mass balance, metabolism, and pharmacokinetics of [14C]amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin’s lymphoma, in healthy Chinese volunteers](https://www.frontiersin.org/files/myhome article library/1478234/1478234_Thumb_400.jpg)
Original Research
Accepted on 11 Nov 2024
in Drug Metabolism and Transport
Original Research
Published on 08 Nov 2024
in Drug Metabolism and Transport
Original Research
Accepted on 07 Nov 2024
in Drug Metabolism and Transport
Original Research
Published on 07 Nov 2024
in Drug Metabolism and Transport
Original Research
Published on 06 Nov 2024
in Drug Metabolism and Transport
Original Research
Accepted on 05 Nov 2024
in Drug Metabolism and Transport
Mini Review
Published on 05 Nov 2024
in Drug Metabolism and Transport
Original Research
Published on 24 Oct 2024
in Drug Metabolism and Transport
Review
Published on 23 Oct 2024
in Drug Metabolism and Transport
Original Research
Accepted on 22 Oct 2024
in Drug Metabolism and Transport
Original Research
Accepted on 17 Oct 2024
in Drug Metabolism and Transport
Original Research
Published on 09 Oct 2024
in Drug Metabolism and Transport
Correction
Published on 27 Sep 2024
in Drug Metabolism and Transport
Original Research
Published on 23 Sep 2024
in Drug Metabolism and Transport
Original Research
Published on 20 Sep 2024
in Drug Metabolism and Transport
